400-81-05
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 100mg | ￥ űÈūÑÈÈ | -- | -- | -- | -- | -- | -- | ￥ űÈūÑÈÈ | - + |
| 50mg | ￥ ǔƩƓÑÈÈ | -- | -- | -- | -- | -- | -- | ￥ ǔƩƓÑÈÈ | - + |
| 1g | ￥ ƩƩűÈÑÈÈ | -- | -- | -- | -- | -- | -- | ￥ ƩƩűÈÑÈÈ | - + |
| 5g | ￥ ƓǔƞƩÑÈÈ | -- | -- | -- | -- | -- | -- | ￥ ƓǔƞƩÑÈÈ | - + |
| 10g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 5g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 100g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
5.3
[1]. Gachon F, et al. Disposition and metabolism of letosteine in rats. Drug Metab Dispos. 1988;1():853-85.
[]. Jia L. Letosteine. John Wiley & Sons, Ltd, 014.
[3]. Macquet V, et al. A new contribution to the treatment of chronic bronchopneumopathies: letosteine. Lille Med. 199;4(9):35-38.
[4]. Zhou Y, et al. Efficacy and safety of letosteine in the treatment of sputum thickening and expectoration difficulty in patients with respiratory diseases: a multicenter, randomized, double-masked, double dummy, positive drug parallel controlled trial. Pharmazie. 014;9(11):84-849.
H30-H315-H319-H335
P1-P4-P0-P1-P80-P30+P35-P304+P340-P330-P3+P34-P405-P501
GHS0
113819 现货
￥ ƞƓƓÈÑÈÈ -100mg
030 货期咨询
￥ ƓÈūķÑÈÈ -100mg
1805 货期咨询
￥ ūƩņÑÈÈ -1g
184308 货期咨询
￥ ƩÜǔǔÑÈÈ -100mg
138511 货期咨询
￥ ƩƩūūÑÈÈ -50mg
11931 货期咨询
￥ ƩÈǔūÑÈÈ -100mg
15843 货期咨询
￥ ƩƓǔƩǔÑÈÈ -5g
1940593 货期咨询
11933 货期咨询
￥ ÜűƞÑÈÈ -100mg
11930 货期咨询
￥ ƩƓņÜÑÈÈ -100mg
沪ICP备101945号
